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1. Introduction 
During the past few years, considerable attention has been given to the impact of nutrition 
on kidney disease. Interventions that restrict protein intake lower the plasma urea 
concentration, alleviate adverse clinical symptoms, and may slow the progression of chronic 
renal failure (CRF). Although these studies provide a logical explanation for a relationship 
between a low protein diet and altering the progression of functional renal deterioration, 
this beneficial effect is often accompanied by some muscle wasting and malnutrition.  
The question arises whether the effect of a moderate dietary protein restriction could  
be reinforced by enrichment of the diet with fermentable carbohydrates, since  
these carbohydrates may stimulate the extra-renal route of nitrogen (N) excretion, via the 
fecal route. 
At a physiological level, there is two routes to eliminate N: urine and feces. Our results 
show that it is possible to increase the N fecal route excretion by reducing the protein 
supply and increasing fermentable carbohydrate availability. This additional dietary 
manipulation seems to be very interesting in case of renal deficiency in animal models and 
in humans. The modification of the urea N enterohepatic cycling by fermentable 
carbohydrates is likely to promote proliferation of the large intestine microflora, which 
could be an interesting approach to deviate a part of the N excretion to feces as a 
consequence of N utilization by the bacteria. Conversely, a large proportion of the N 
released by urea hydrolysis in the digestive tract may be recycled, via the reabsorption of 
ammonia, and could contribute thus to reduce the need of N. 
In the domain of preventive nutrition, the first recognized effect of dietary fibers was to 
regularize the digestive transit, especially in the case of constipation. However, during the 
past decades, some other interesting effects have been reported, especially lipid-lowering 
effects, improvement of blood glucose control, reduction of colon cancer risk and increase 
of the availability of some cations. In contrast, the efficacy of the dietary fibers in the 
treatment of CRF has been less investigated although the availability of dietary fibers 
should profoundly alter the microflora metabolism and proliferation, and as a result N 
metabolism. 
The aim of this chapter is to review, for the course of CRF, the capacity of an additional 
manipulation of diet in increasing fermentable carbohydrates which can stimulate  
the transfer of urea into the large intestine and shift N excretion from the urine to  
the feces. 
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2. Relationship between fermentable carbohydrate intake and symbiotic 
fermentations in the large intestine 
Originally, fiber was defined to be the components of plants that resist human digestive 
enzymes, a definition that includes lignin and polysaccharides (cellulose, hemicellulose, 
pectin). The definition was later changed to also include resistant starches, along with inulin 
and other oligosaccharides. Pectin is 90 -100% degradable (by the bacteria in the colon), 
hemicellulose is 50-80%, and cellulose is 30-50%. Lignin is completely indigestible. 
Therefore, depending on the concentration of these components in the fiber, the digestibility 
and calorie value of fiber food varies (Anderson et al., 2009; Cummings et al., 2009).  
There is now substantial evidence that fermentative processes similar to those occurring in 
non-ruminant herbivorous and omnivorous species also take place in the human large 
intestine (Cummings, 1984; Macfarlane & Macfarlane, 2009). In many animal species, the 
colon has an important digestive role to recover energy from non-available dietary 
carbohydrates that are not hydrolyzed and absorbed in the upper digestive tract. 
Traditionally, the human large intestine has been considered of as an organ that conserves 
minerals and water, and controls the disposal of indigested products. In recent years, 
research has also focused on the metabolic and digestive effects of various dietary fibers. In 
humans, it has been shown that the development of symbiotic fermentations had beneficial 
effects via the absorption and the utilization of short-chain fatty acids (SCFAs) (Macfarlane 
& Cummings, 1991; Elia & Cummings, 2007). 
The breakdown of nutriments transfered from the ileum into the large intestine is carried 
out by diverse population of bacteria. In fact, bacteria are ubiquitous in the digestive tract, 
but the main part of them is confined in the large intestine. In humans, there are from 1011 to 
1012 germs/g of content which are divided up into no less than 400 various species, this 
represents 35 to 55% of the digestive contents weight (Stephen & Cummings, 1980). This 
flora, mainly anaerobic, establishes relationships of symbiosis with the host. In addition, 
they probably fulfills a protective effect towards pathogenic species. The principal 
substrates for the bacteria are dietary fibers (non-starch polysaccharides, 10 to more 50 
g/day), resistant starches (8 to 40 g/day) and oligosaccharides, and as well as proteins. 
Concerning the quantity of mucus (coming from the higher parts of the digestive tract or 
secreted in "situ") and the sloughed epithelial cells, there is still an uncertainty about their 
quantitative contribution. 
In humans, the major end-products of carbohydrate breakdown are SCFA (essentially 
acetate, propionate and butyrate), and the gases H2 and CO2 (Fig. 1). The total concentration 
in SCFA is relatively stable in the large intestine: in the proximal part (cecum, proximal 
colon), they are generally found in the range of 80 to 150 mmol/L and, in the distal colon, 
they may be lower (from 50 to 100 mmol/L) (Macfarlane & Cummings, 1991). The SCFA are 
the main anions in the large intestine. For some osmotic reasons, it is expectable that they 
could hardly exceed 130-150 mmol/L. However, when the pH of fermentation is very acid 
(close to 5), the proportion of SCFA under protoned form becomes very important and then, 
it is possible to find concentrations higher than 150 mmol/L for SCFA alone or, more often, 
for SCFA + lactate (Macfarlane & Cummings, 1991). 
The availability of fermentable carbohydrate influences the molar proportions of SCFA in 
the colon. Schematically, fermentations with a pH higher than 6.5 are relatively slow and 
favor the production of acetic acid. Fermentations close to a pH 6.0-6.5 are generally 
favorable to high propionic acid fermentations, while acidic fermentations (close to 5.5) give 
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rise to the appearance of notable concentrations of lactate. Other products of the 
fermentation include branched-SCFA from the deamination of branched-chain amino acids, 
ammonia, various carboxylic and phenolic acids, and amines (Cummings & Macfarlane, 
1991). The branched-SCFA (isobutyrate, isovalerate, 2-methylbutyrate) are very low in the 
proximal part of the large intestine (less than 10% of the total SCFA) where takes place a 
very active bacterial anabolism. In the distal part of the large intestine, the exhaustion of 
fermentable carbohydrates and the rise of the luminal pH favor proteolysis which chiefly 
affects bacterial protein, together with desaminations of AAs and production of the 
branched-SCFA. In humans, these last could be 35-40% of the total SCFA in the distal colon 
(Macfarlane & Cummings, 1991; Tarini & Wolever, 2010). 
 
 
Fig. 1. Conversion stages of polysaccharides in SCFAs and other fermentation products by 
microflora in the large intestine 
On the other hand, active fermentation stimulates the bacterial growth and leads to a 
considerable enlargement of the colonic contents and an hypertrophy of the cecal wall in rat 
(Levrat et al., 1991; Younes et al., 1995a). These changes results in an enlargement of the 
exchange surface area between blood and the luminal fluid, together with an increase of 
colonic blood flow. This in turn stimulates the exchanges of urea and ammonia N between 
blood and digestive lumen (Rémésy & Demigné, 1989; Levrat et al., 1991; Younes et al., 
1995b; 1997). The relative hypertrophy of the cecal wall in rat fed fermentable carbohydrates 
can be ascribed to high concentrations of SCFA, especially butyrate, which is considered as a 
particularly potent trophic factor (Young & Gibson, 1995; Canani et al., 2011). In this view, it 
must be noticed that resistant starch exerts a marked trophic effect on colonic mucosa 
(Demigné & Rémésy, 1982; Bauer-Marinovic et al., 2006). Data on the action of fiber on 
colonic wall in humans are lacking, but it is possible that fermentable carbohydrates exert 
similar trophic effect (Jahns et al., 2011). 
Dietary fibers contribute to reduce transit time in the large intestine by exerting a bulk effect 
directly or indirectly by the increase of bacterial mass (Luria, 1960). In fact, there is a direct 
relationship between an accelerated transit time, an enhanced fecal bacterial mass and fecal 
N excretion (Stephen et al., 1987). Furthermore, we have shown that the increase in fecal N 
excretion was compensated for by a decrease in urinary urea (Younes et al, 1995a,b, 1996a, 
1997). The laxative effects of fermentable carbohydrate are particularly interesting to 
prevent and to treat the constipation (frequent in patients with CRF) (Burkitt et al., 1974; 
Eastwood, 1983; Turnbull et al., 1986). 
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3. Relationship between fermentable carbohydrate intake and enterohepatic 
cycling of urea and ammonia 
How do these changes in bacterial mass and stool bulk affect N metabolism? Fermentation, 
by stimulating microbial growth, increases the N requirements of microorganisms. Nitrogen 
reaching the colon is mainly of endogenous origin, protein coming from the small intestine, 
or urea coming either directly from the blood or from the small intestine. Indeed, with diets 
which provide a small quantity of fermentable carbohydrates, only small amount of 
undigested dietary proteins and endogenous proteins (pancreatic enzymes and sloughed 
micosal cells) reach the large intestine. Here, they will be hydrolyzed and used for the 
microbial proliferation in the large bowel, but many of the end-products of protein 
fermentation are undesirable. However, when the intake of fermentable carbohydrates 
increases, N transfer may be not enough to promote an optimal bacterial growth. In such 
conditions, several investigations (Demigné & Rémésy, 1979; Langran, 1992; Younes et al. 
1995a, 1995b, 1996a, 1997; Geboes et al., 2006) have shown that the blood urea constitutes the 
largest and the most available source of N for bacterial protein synthesis. As a result, fecal N 
excretion is significantly increased by comparison with fiber-free diets. (Younes et al., 1995a, 
1995b, 1996a, 1997; Geboes et al., 2006; Wutzke, 2010) 
In the 1980s, several hypothesis have been put forward for the manner in which fermentable 
carbohydrates brings about this effect : (i) the fecal N could originate from structural 
proteins of plant cell wall (Saunders & Betschart, 1980), and (ii) the fiber could decrease the 
digestibility of dietary protein in small intestine (Bender et al., 1979; Schneeman & Gallaher, 
1986). Although these N sources may be significant, another source of fecal N is bacterial 
proliferation (Stephen, 1987). Bacteria make up ~ 55% of dry stool weight in humans on a 
western diet (Stephen & Cummings, 1980), and because bacteria are composed of 7-8% of N 
(dry weight) (Stephen, 1987), any increase in their colonic proliferation will increase fecal 
mass and N excretion. 
Urea disposal in the large intestine has been shown in various species including humans 
(Demigné & Rémésy, 1979; Viallard, 1984; Forsythe & Parker, 1985; Moran & Jackson, 1990; 
Langran et al., 1992). In humans, it has been estimated that the urea hydrolyzed in the large 
intestine could represent approximately one-third of total urea produced by the liver 
(Richards, 1972). Various factors control the urea hydrolysis: the rate of urea transfer to the 
site(s) of hydrolysis, the activity of the bacterial urease, the demand of ammonia for the 
bacterial protein synthesis, and the availability of other N sources (Langran et al., 1992). 
However, some studies suggest that the human colon, unlike the colon of many animals, is 
relatively impermeable to urea and at most, a passive flux might allows diffusion of about 
20% of the amount of urea destroyed (Bown et al., 1975; Moran & Jackson, 1990). But, these 
studies have entailed preliminary cleansing of the colon; yet removal of digestive 
constituents (bacterial urease, SCFA, carbon dioxide) is known to affect gastrointestinal 
permeability to urea (Dobbins & Binder, 1979; Kennedy & Milligan, 1980). Another study 
has shown, by direct measurements of the contribution of endogenous urea to fecal 
ammonia, that urea is a relatively minor source (8%) of fecal ammonia in healthy subjects 
with intact renal function (Wrong et al., 1985). The intensity of urea contribution to colonic 
ammonia is certainly dependent on the fermentable carbohydrate availability for 
maintaining highly active urease activity. Indeed, the transfer of urea is proportional to the 
concentration gradient of urea across the colonic wall; this explains the stimulatory effect of 
colonic bacteria via their ureolytic activity to promote urea uptake by the colon. 
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Consequently, in the presence of fermentable carbohydrates (particularly oligosaccharides 
which exerts osmotic effects and favors the ureolytic activity) and in case of hyperuremia, 
this transfer into the colon may become considerable (Fig.2A) (Younes et al., 2001). Some 
urea could be utilized in the distal ileum which presents a high permeability for this 
molecule (Gibson et al., 1976). However, the bacterial population in the terminal ileum is 
only one thousandth or so of that in the colon. Although the permeability of human ileum to 
urea is higher than that of the colon, the transfer of urea to the colon may be substantial 
because the transit time in the colon is longer. 
 
 
Fig. 2. Effects of dietary conditions on cecal nitrogen flux in control (C) or uremic (U) rats 
fed fiber-free (FF) or fructooligosaccharide (FOS) diets. * Significat difference (P<0.05) 
between groups of rats fed FF diets and groups of rats fed FOS diets. t Significat difference 
(P< 0.05) between groups of control rats and uremic rats. § Significat difference (P< 0.05) 
between groups of rats fed the moderately low protein level and those fed the moderately 
high protein level. 
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A part of ammonia produced from urea will be used for bacterial protein synthesis which 
will be eliminated in the stool, and therefore fecal N excretion is increased (Younes et al., 
1995; Bliss et al., 1996; Younes et al., 1997). Another part of ammonia will be absorbed and 
converted in the liver to urea or recycled by different ways for non-essential AAs synthesis 
such as glutamate and glutamine (Rémésy et al., 1997). Moreover, some AAs coming from 
bacterial metabolism could be recovered by the host, but the importance of this way is still 
poorly documented (Jackson, 1995, Aufreiter et al., 2011). In fact, the incorporation of 
ammonia into bacterial protein mainly leads to an irreversible loss of N via the fecal route 
and it is more significant when the quantity of fermentable carbohydrates is high. 
Our results support the view that there is a close relationship between the net flux of urea N 
towards large intestine and fecal N excretion, hence a lowering of plasma urea (Fig. 3) 
(Younes et al., 2001). A high rate of urea transfer into the cecum is favored by an enlarged 
surface area of exchange between blood and the luminal fluid and by an accelerated blood 
flow in the cecum (Rémésy & Demigné, 1989; Younes et al., 1997). All these parameters are 
enhanced by feeding various fermentable carbohydrates. In turn, a high supply of urea 
elevates the cecal pool of ammonia and elicits a substantial absorption of ammonia in spite 
of a marked acidification of cecal contents (Fig. 2B) (Younes et al., 2001). In fact, ammonia 
and SCFAs are generally considered to be transported across biological membranes as 
uncharged molecules (Bödeker et al., 1992). In colonocytes (intracellular pH 7.0-7.1) SCFAs 
and ammonia will be dissociated again, and it is conceivable that protons required for 
NH4+ formation arise from SCFA dissociation. 
 
 
Fig. 3. Effects of dietary conditions on plasma urea concentration in control (C) or uremic 
(U) rats fed fiber-free (FF) or fructooligosaccharide (FOS) diets. * Significat difference 
(P<0.05) between groups of rats fed FF diets and groups of rats fed FOS diets. t Significat 
difference (P< 0.05) between groups of control rats and uremic rats. § Significat difference 
(P< 0.05) between groups of rats fed the moderately low protein level and those fed the 
moderately high protein level. 
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Thus, the enterohepatic cycle of urea and ammonia N observed in numerous works, 
(Stephen & Cummings, 1980; Forsythe & Parker,1985; Rémésy & Demigné, 1989; Moran & 
Jackson, 1990; Jackson, 1995) and as represented in Fig 4, suggests that this process is not 
necessarily a futile cycle. It participates in both the elimination of urea N by the fecal route 
and in the N salvage, particularly with a low protein diet enriched with fermentable 
carbohydrate. 
 
 
Fig. 4. Impact of fermentable carbohydrate intake on N enterohepatic cycle. 
4. Present dietary approach to treat the patient with chronic renal failure 
Until now, researches and dietetic propositions for CRF patients were based on the 
nephroprotection concept, making an attempt to maintain a satisfactory nutritional state. In 
other words, the aim of these researches and dietetic propositions were to delay the 
progression of renal deterioration, reduce urea toxicity and limit muscle wasting. Numerous 
studies have reported a reduction of the renal failure progression with a low protein diet. In 
fact, a linkage between glomerular hyperperfusion, hyperfiltration, and structural changes 
was suggested in studies involving dietary protein restriction (Brenner, 1985; Levey et al., 
1996a, 1996b; Fouque et al., 2011, Garneata L & Mircescu G, 2011).  
The relationship between the dietary protein restriction and renal failure progression is 
known for a long time. Approximately 60 years ago, Addis speculated that the severity of 
CRF could be improved by reducing the dietary protein level (Addis, 1948). Since then, a 
considerable body of evidence has been accumulated suggesting the slowing or temporary 
halting of the progression of CRF. In fact, a large number of diets have been proposed and 
more or less widely used during the last decades. The overall strategy was to reduce N 
intake by selecting foods of vegetable origin and by supplementing this "basal diet" with 
small amounts of protein of high biological value to satisfy the requirement for essentials 
amino-acids (AAs). Another approach was to use a supplementation of essentials AAs or 
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keto acids (KAs) (Giovannetti, 1989; Lin, 2009), however, the use of these KAs was not 
particularly convincing (Klahr, 1994; Aparicio et al ., 2009). 
Studies in CRF patients (randomized trial or not) reported that starting a restriction of 
dietary protein and phosphate early in the course of CRF has a considerable influence on the 
rate of progression of this disease (Mitch, 1991 ; Levey et al., 1996a, 1996b ; William & 
Maroni, 1998 ; Mackenzie & Brenner, 1998, Garneata & Mircescu, 2010; Kalista-Richards, 
2011; Fouque et al., 2011a). In experimental models, dietary protein restriction reduces the 
load of N metabolism end-products for excretion, limits the adaptive changes in remnant 
nephrons, and slows the tendency to renal disease progression (Hostetter, 1986). Despite the 
unambiguous support from experimental studies, the conclusive results are often regarded 
as unconvincing and as they do not meet strict statistical rules (Gretz & Strauch, 1986; 
Garneata & Mircescu, 2010). 
Other works carried on within MDRD study (The Modification of Diet in Renal Disease: a 
randomized and controlled trials), it appeared that the protein restriction gives only a slight 
benefit for the patients with a moderate renal failure (Mackenzie & Brunner, 1998). 
Moreover, when the renal failure was at an advanced stage, the protein restriction, even 
severe and supplemented with KAs, did not really reduce the progression of the disease 
(Klahr, 1994). In fact, there is an initial diet-induced decline in GFR followed by a long-term 
beneficial effects of dietary protein restriction (appeared after 4 months), with an 
improvement of functioning nephrons conservation (Mackenzie & Brunner, 1998). This 
initial rapid reduction in GFR, accompanied by a reduction in protein excretion rates, is a 
functional effect and does not reflect a further loss of nephrons (levey et al, 1996c). In second 
MDRD study, the authors concluded that the addition of KAs did not exert a beneficial 
effects (Klahr et al., 1994), and that for patients with a low GFR (< 25 mL/min/1.73 m2), a 
dietary protein intake of 0.6 g/kg/day should be prescribed (Levey et al., 1996a). 
The question arises therefore on to the degree of the protein restriction. For health 
maintenance, a minimum daily supplies in protein was defined by the FAO in the range of 
0.5 g/kg/day (FAO/WHO/UNU, 1985). In practice, in patients who are pre-dialysis and 
treated by a maintenance method, a protein supply lower than 0.6 g/kg/day has been 
proposed in association with KAs supplementation (El Nahas & Coles, 1986). However, the 
risk of protein malnutrition, and the constraints inherent to this supplementation led to 
recommend a moderate dietary protein supply of about 0.8 g/kg/day (Klahr et al., 1994 ; 
Tom et al., 1995 ; Levey et al., 1996a; Dumler, 2011; Fouque et al., 2011a). 
In dialysis patients, the protein restriction question is more complex because there is a 
aggravated risk of protein-caloric undernutrition with an increased morbidity and mortality 
(30% of the dialysis patients) (Parker et al., 1983; Young et al., 1991). This leads to a rejection 
of protein restriction with, as a result, a proposed supply in the 1 to 1.2 g/kg/day range 
(Bergström, 1995 ; Cianciaruso et al., 1995 ; Qureshi et al., 1998 ; Antunes et al., 2010). 
However, it is still uncertain whether this policy is enough in order to equilibrate the N 
balance in these patients since there is a proportional relationship between the protein 
supply and the rate of N catabolism as it is estimated by the PCR (protein catabolism rate) 
(Movilli et al., 1993 ; Harty et al., 1994; Fouque et al., 2011a).  
The protein-caloric undernutrition observed in dialysis patients is often linked to a deficient 
supply (Ikizler et al., 1995 ; Pollock et al., 1997, Kalantar-Zadeh, 2003), which is itself often 
linked to a depressed appetite (Bergström, 1995; Van Der Eijk & Farinelli, 1997). Moreover, 
seances of dialysis constitute in itself protein catabolism stimulation by means of an 
inflammatory response in contact with the membrane which induces the secretion of 
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hypercatabolic factors like interleukins (Valderrabano et al., 1996). The loss in glucose (25 
g/seance) and in AAs (10-12 g/seance) can also decrease the protein anabolism capacity and 
thus led to an increased net proteolysis (Gutierrez et al., 1994; Ikizler et al., 1994). In practice, 
and in certain important undernutrition situations, it is necessary to provide a nutritional 
complement, especially AAs which are injected intravenously during the seance of dialysis. 
The dialysis fluid can be used also as a nutritional vehicle for supplementation of N (Chazot 
et al., 1997). The pre-dialytic parenteral nutrition seems to yield good results in order to 
preserve nutritional status (Cano et al., 1990), and it sounds to improve both morbidity and 
mortality on retrospective data (Capelli et al., 1994; Chertow et al., 1994). 
Others studies showed that the catabolism rate of AAs and net protein synthesis could be 
affected by the speed of protein digestion (Boirie et al., 1997, Koopman et al., 2009). Thus, 
soluble proteins of milk are more quickly oxidized and lead to a less efficience protein 
synthesis than casein. It is more helpful to have slowly digested carbohydrate than rapid 
carbohydrate, and in the same view, it also would be helpful to select slowly degradated 
proteins (in particular plant proteins). This approach has not been sufficiently investigated 
in comparison with the quantitative approach. 
In the elderly, the development of renal diseases is frequently linked to pathologies as 
diabete and/or cardiovascular diseases (Attman & Alaupovic, 1990; Parillo et al., 1988; 
Blicklé et al., 2007; Ng et al., 2011). Consequently, it is important to control the supply of 
both carbohydrates and lipids. In this view, it has been shown that diets enriched in fiber 
can improve blood glucose control and reduce serum cholesterol levels in diabetic patients. 
It has been also shown that the preservation of remaining nephron in nephrectomized rats is 
tightly dependent on the nature of the carbohydrate ingested. The kidney preservation 
could be, thus, improved by the supply of complex carbohydrates rather than simple 
carbohydrates (Lakshmanan et al., 1983; Kleinknecht et al., 1986). 
Control of lipid supply and the balance in fatty acids is also important since CRF patients 
are frequently hyperlipidemic with an increase of the total amount of plasma cholesterol, 
triglycerides, phospholipides, LDL and VLDL and a decrease in HDL (Attman & Alaupovic, 
1990; Gentile et al., 1995; Axelsson, 2010 ; Ng et al., 2011).  In some animal models with a 
CRF, it has been shown that low-fat diets have protective effects on the progression of 
glomerular damages (Kher et al., 1985; Diamond & Karnovsky, 1987; D’Amico et al., 1992; 
Brown et al., 2000).  
Furthermore, it is well known that diets for the CRF patients must be restricted in 
phosphorus and potassium and provide a calcium supplementation in order to help the 
fecal elimination of the phosphate (Gin & Rigalleau, 1995; Fouque et al., 2011b). Because of 
nutritional constraints inherent to the renal deficiency, it is particularly important to 
maintain the energetic balance of the patients and to provide a nutrition rich in protective 
factors, in particular, antioxidants to limit the severity of oxidative stress. 
5. Role of fermentable carbohydrate in the dietetic of chronic renal failure: 
Experimental bases and discussion 
There are synergistic actions between high fermentable carbohydrate diets and low protein 
diets, particularly as to their plasma urea lowering effects, and, hence progression of CRF. 
Although the primary determinant of the plasma urea concentration is the dietary protein 
level, feeding fermentable carbohydrate has also an important effect on this parameter 
(Younes et al., 1995a,b, 1996a, 1997; Bliss et al., 1996). Consequently, it is interesting to 
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promote low protein diets, rich in various unavailable carbohydrates. This can be obtained 
by consuming a diet rich in plant products (cereal products, leguminous, vegetables and 
fruits). However, these diets are also particularly rich in potassium. Thus, to deal with this 
drawback, it is necessary to select foods rich in fermentable carbohydrate (resistant starch 
and oligosaccharides) to restrict the potassium supply. 
Extra-renal urea excretion via the enteral route may be clinically relevant in patients with an 
impaired renal function. In CRF patients, the question of efficiency of the dietary protein 
restriction has seldom been considered according to the availability of fermentable 
carbohydrates. Consequently, it is necessary to carry out experiments in order to confirm 
these hypotheses and to determinate the optimal fermentable carbohydrate and protein 
supply for the protection of the renal function. 
The selection of diets rich in slowly digested carbohydrates is particularly important in 
order to reduce the N catabolism because a part of AAs is metabolized for glucose 
production if the supply of carbohydrates is not optimal. In dialysis patients, catabolism is 
accelerated which theoretically increases the N demand. However, any increase of dietary N 
is expected to rise in parallel N catabolism and consequently precludes any significant 
improvement of the N balance. For this reason, it is important to increase the supply of the 
slowly digested carbohydrates in the diet of these patients which can contribute to decrease 
the hepatic gluconeogenesis from AAs. Therefore, in dialysis patients, it should be 
important that the fermentable carbohydrate would be provided together with a substential 
decrease of the protein level in the diet. This is possible because the increase of complex 
carbohydrate led to a better utilization of dietary N. It would also be important, in future, to 
explore the interest of slowly digested proteins. 
The efficiency of fermentable carbohydrates to reinforce urea-lowering of a low-protein diet 
has been illustrated by experimental works in the rat (Younes et al., 1995b, 1996a, 1998, 
2001). It appeared possible, using a diet rich in fermentable carbohydrates and low in 
protein, to drastically reduce the concentration of plasma urea, down to 0.75 mmol/L 
(Younes et al., 1996a). This urea lowering-effect of fermentable carbohydrates has been also 
observed in rat models of experimental renal failure (Younes et al., 1997, 1998, 2001) and in 
patients with CRF (Rampton et al.,1984; Bliss et al. 1996; Younes et al., 2006).  
In nephrectomized rats, we have shown that feeding fermentable carbohydrates decreased the 
concentration of plasma urea from 32 mg/dL to 22 mg/dL, a 30% decrease. When, in addition, 
the dietary protein level was reduced from 18% to 10%, plasma urea was decreased from 56 
mg/L to 22 mg/dL, a 60% decrease (Younes et al., 2001) (Fig. 3). Moreover, our results 
obtained in nephrectomized rats showed that the fermentable carbohydrates were all the more 
efficient to shift N excretion from the urinary route towards the fecal route because the protein 
level was low. Thus, we have shown that with a 18% protein level, fecal N represented 22% of 
total N excretion in rats fed fermentable carbohydrate diet vs. only 13% in rats in fiber-free 
conditions; whereas, with a lower protein level (10% casein diet) fecal N represented 40% of 
total N excretion (Fig. 5C) (Younes et al., 2001). As a result of this increase in fecal N excretion, 
the net effect of feeding fermentable carbohydrates with a dietary protein restriction was to 
decrease urinary N excretion from approximately 270 mg/day (18% casein, fiber-free diet) to 
approximately 100 mg/day (10% casein, fermentable carbohydrate diet); this represents a 63% 
decrease of urinary N (Fig. 5B) (Younes et al., 2001).  
We have also compared the effects of fermentable carbohydrate intake in normal  
and nephrectomized rats: the data indicates that the hypertrophy of the remaining kidney 
(+40-50%) was effective in ensuring a relatively high rate of urea excretion, but it was not  
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Fig. 5. Effects of dietary conditions on fecal and urinary N excretions and fecal percentage of 
total N excretion in control (C) or uremic (U) rats fed fiber-free (FF) or fructooligosaccharide 
(FOS) diets. * Significat difference (P<0.05) between groups of rats fed FF diets and groups 
of rats fed FOS diets. t Significat difference (P< 0.05) between groups of control rats and 
uremic rats. § Significat difference (P< 0.05) between groups of rats fed the moderately low 
protein level and those fed the moderately high protein level. 
sufficient to counteract increased blood urea levels. Elevated blood urea had a minute 
influence on urea cycling and ammonia absorption in large intestine in rats fed the fiber-free 
diet. In contrast, a large increase in N fluxes through the large intestine was observed in 
nephrectomized rats fed fermentable carbohydrates (Fig. 2A,B). In these animals, a large 
part of urea taken up was reabsorbed as ammonia. This accelerated transfer of N in the large 
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intestine results in a slightly higher fecal excretion in nephrectomized rats, when compared 
to normal rats (Fig. 5A). In turn, this led to a significant decrease of plasma urea, less 
pronounced in nephrectomized rats fed fermentable carbohydrate diet (-30%) than in 
normal rats (-45%) (Fig. 3). The urinary N excretion was also more effectively lowered by 
fermentable carbohydrates in normal rats (-30%) than in nephrectomized rats (-20%) (Fig 5B) 
(Younes et al., 2001). 
 
 
Fig. 6. Effects of dietary conditions on stool and urinary N excretions and the total N 
excretion in chronic renal failure patients consoming a fermentable carbohydrates (FC)-free 
diet or an enriched-FC diet. * Significat difference (P<0.05).  
The question which arises is to know if the fermentable carbohydrates have the same 
effects on N metabolism in healthy men as in those with CRF. To our knowledge, this 
point has not been well documented. In CRF patients, supplementation with gum arabic 
or ispaghula (hemicellulose) has been shown to reduce serum urea N levels by 12% and 
19%, respectively (Rampton et al., 1984; Bliss et al. 1996). In parallel, the total fecal N 
excretion, and particularly the bacteria fraction, was significantly increased with 
fermentable carbohydrates and accounted for 59% of the total increase in stool N contents 
(Stephen et al., 1995; Bliss et al., 1996). This suggests that the large intestine can partially 
compensate for the renal failure, provided that an appropriate supply of fermentable 
carbohydrate and protein is allowed. More recently, in a prospective study (Younes et al., 
2006), the impact of fermentable carbohydrates (40 g/day) on uremia and N excretion 
ways was investigated during five weeks in CRF patients in presence of a controlled 
protein diet (0.8 g/kg/day). Patients were their own controls and treated by crossing over 
method after randomization (5 weeks with fermentable carbohydrates vs 5 weeks without 
fermentable carbohydrates). Feeding fermentable carbohydrates significantly increased 
the quantity of N excreted in stools from 2.1 ± 0.8 to 3.2 ± 1.1 g/day (P < 0.01) and 
decreased, in parallel, the urinary N excretion from 9.4 ± 1.7 to 8.3 ± 1.4 g/day (P < 0.01). 
The total N quantities excreted by the two ways were unchanged by the fermentable 
carbohydrates, which showed that the FC was efficient to shift N excretion from the 
urinary route toward the digestive route (Fig. 6).  
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In consequence to this increase of urea transfer into the colon, the plasma urea concentration 
was significantly decreased from 26.1 ± 8.7 to 20.2 ± 8.2 mmol/L (P < 0.05). In this short trial, 
we have not shown a significant difference in the concentration of plasma creatinine, nor in 
the creatinine clearance. Any changes in the nutritional status parameters (albumin, 
prealbumin) have been noted. However, the body weight was significantly increased (+ 600 
g) when the diet of patients was enriched in fermentable carbohydrates.  
6. Conclusion 
In CRF, the plasma concentration of the end-products of protein catabolism, especially urea, 
is increased. Although most of the dietary attempts to treat this disease and to decrease the 
serum urea N involve a reduction of N intake, an additional manipulation of diet would be 
to add fermentable carbohydrates, which can increase N excretion in the feces. Our works 
and those of others have shown that a low protein diet remains beneficial and the 
combination of these two dietary changes brings about the greatest fecal urea excretion, 
together with a reduced urinary excretion. Of course, the colon could not substitute 
completely itself to the renal function. Reciprocally, when the digestive elimination route is 
disturbed, the consequences of renal failure are amplified. 
In practice, it is recommended to increase fiber gradually by using a large variety of vegetal 
products to provide 35-40 g of fiber daily (24 g from cereals products, leguminous seeds, 
and other starchy foods; 8 g from vegetables; 2-4 g from fruits; 4 g from resistant starches, 
oligosaccharides and various hydrocolloids). Nevertheless, because intolerance seems to 
exist toward certain food, it is necessary to ensure that the recommended products are well 
tolerated by considering the supply of potassium, which is particularly present in fruits. 
Because of social and family environments, it is difficult to change dietary habits; thus, it is 
sometimes necessary to recommend preparations enriched with fermentable carbohydrates. 
Finally, it is also important to indicate that a food rich in complex plant products could help 
facilitate the elimination of cholesterol and, hence, prevent the vascular complications 
caused by CRF. Moreover, plant products are rich in antioxidant micronutriments are very 
important in order to prevent lipid peroxidation and the production of free radicals, which 
is exaggerated in the CRF patients.  
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